Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spiro Devices was a New York medical device company formed in 2020 by Newlab, 10XBeta, and Boyce Technologies, together with other collaborators, to develop and manufacture a low-cost emergency ventilation device during the COVID-19 crisis. Its flagship product, Spiro Wave, is an automated manual resuscitator intended to provide basic ventilator functionality as a bridge solution when conventional ventilators are unavailable. The company moved rapidly from concept to production support, won a U.S. Army xTech COVID-19 Ventilator Challenge award, obtained FDA Emergency Use Authorization during the pandemic, and was selected to supply devices for New York City. Available evidence indicates the company was a pandemic-response venture centered on a single emergency respiratory device rather than a traditional therapeutics pipeline company. Publicly visible recent operating information is limited, suggesting it is no longer an active standalone operating business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spiro Devices.